HemoCue Logo white

Measuring eosinophils can be an important indicator of how to treat COPD patients

When a patient displays symptoms of chronic obstructive pulmonary disease, there are multiple treatment options.

For some COPD patients, especially those with severe-to-very-severe airflow limitation, inhaled corticosteroids (ICS) can be an effective option.

However, ICS, like most medicines, may cause some unwanted side effects, so it is vital to make accurate treatment decisions.

Measuring levels of eosinophils can give an indication of the efficacy of ICS. International guidelines, including the Global Initiative for Chronic Obstructive Lung Disease, recommend measuring blood eosinophils to help identify COPD patients who are suitable for ICS treatment.

HemoCue WBC DIFF System provides lab-quality measurement of eosinophils directly at the point of care, allowing you to recommend suitable treatment when and where needed the most. 

Get to know more about point-of-care testing of eosinophils with HemoCue WBC DIFF System

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Landingpage - COPD Campaign All EU

Five minutes and a single drop of blood help you gain a more complete clinical picture

HemoCue WBC DIFF System provides you with a patient’s total white blood cell count with a five-part differential, including eosinophils.
Using WBC DIFF at the point-of-care to measure eosinophils:

  • Helps ensure accurate, individualized treatment – prescribe the right amount of medicine for the right patient, preventing exacerbation due to inappropriate treatments or incorrect dosages.
  • Saves time and money – by testing at the point of care, you can improve patient flow and patients do not have to wait for results to come back from a lab.
  • Aids in infection management – COPD patients tend to be more susceptible to infections. WBC DIFF can help distinguish between bacterial and viral infections so you only have to prescribe antibiotics when absolutely needed.

Using a point-of-care method for measuring eosinophils can help identify patients suitable for specific treatments and give guidance on how to adjust medication.

  • White blood cell count with a 5-part differential in just 5 minutes
  • Easy to use by non-laboratory personnel after a brief training
  • Capillary or venous samples

HemoCue has been a leader in Hb point-of-care medical diagnostics for over 40 years. We specialize in giving healthcare providers lab-quality results comparable to that of a clinical lab.

HemoCue Logo white

www.hemocue.com

© 2022 HemoCue

Distributed in Australia and New Zealand by  –
Radiometer Pacific Pty Ltd
PO Box 5134, Mt Waverley VIC, 3149, Australia
Phone (AUS) +61 1800 247 254
Phone (NZ) +64 0800 723 722
Email: sales@radiometer.com.au
Website: www.radiometer.com.au